Navidea Biopharmaceuticals Announces 2012 Annual Meeting Results
15:00 EDT 15 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical
company focused on precision diagnostic radiopharmaceuticals, today
announced the results of voting at its 2012 Annual Meeting of
Stockholders (the Annual Me...
Other Sources for this Article
Navidea Biopharmaceuticals, Inc.
Brent Larson, Sr. VP &
CFO
614-822-2330
More From BioPortfolio on "Navidea Biopharmaceuticals Announces 2012 Annual Meeting Results"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
